Plasmodesmata. A Not So Open-and-Shut Case

מאת Oparka, K. J., Roberts, A. G.
יצא לאור 2001

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

מאת Zielinski, Christoph C, Pinto, Carmine
הוצא לאור ב ESMO Open (2016)

ESMO Open—Cancer Horizons and the future of oncology

מאת Zielinski, Christoph C
הוצא לאור ב ESMO Open (2016)

CSCO joins ESMO Open—Cancer Horizons

מאת Zielinski, Christoph C, Wu, Yi-Long
הוצא לאור ב ESMO Open (2016)

ESMO Open: news in breast cancer 2019

מאת Lambertini, Matteo
הוצא לאור ב ESMO Open (2020)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

מאת Ohe, Yuichiro, Zielinski, Christoph
הוצא לאור ב ESMO Open (2017)

ESMO Open special series on new emerging targets in cancer immunotherapy

מאת Lambertini, Matteo
הוצא לאור ב ESMO Open (2020)

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

מאת Morgan, Gilberto, Preusser, Matthias, Zielinski, Christoph
הוצא לאור ב ESMO Open (2020)

One year of ESMO Open: Cancer Horizons—where are we going from here?

מאת Zielinski, Christoph
הוצא לאור ב ESMO Open (2017)

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

מאת Preusser, Matthias
הוצא לאור ב ESMO Open (2019)

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion

מאת Burke, Patrick W, Hoelzer, Dieter, Park, Jae H, Schmiegelow, Kjeld, Douer, Dan
הוצא לאור ב ESMO Open (2020)

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

מאת Banerjee, Susana, Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N, Oaknin, Ana, Ray-Coquard, Isabelle
הוצא לאור ב ESMO Open (2020)

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

מאת Awada, Ahmad, Gligorov, Joseph, Jerusalem, Guy, Preusser, Matthias, Singer, Christian, Zielinski, Christoph
הוצא לאור ב ESMO Open (2019)

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

מאת Lambertini, Matteo, Preusser, Matthias, Zielinski, Christoph C
הוצא לאור ב ESMO Open (2019)

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

מאת Lamarca, A., Foster, L., Satyadas, T., Siriwardena, A., Valle, J.W.
הוצא לאור ב ESMO Open (2021)

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

מאת Peleg Hasson, S., Brezis, M.R., Shachar, E., Shachar, S.S., Wolf, I., Sonnenblick, A.
הוצא לאור ב ESMO Open (2021)

Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]

מאת Shi, L., Xu, C., Ma, Y., Ou, Q., Wu, X., Lu, S., Shao, Y., Guo, R., Kong, J.
הוצא לאור ב ESMO Open (2021)

Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’: [ESMO Open Volume 6, Issue...

מאת Lee, R.J., Wysocki, O., Bhogal, T., Shotton, R., Tivey, A., Angelakas, A., Aung, T., Banfill, K., Baxter, M., Boyce, H., Brearton, G., Copson, E., Dickens, E., Eastlake, L., Gomes, F., Hague, C., Harrison, M., Horsley, L., Huddar, P., Hudson, Z., Khan, S., Khan, U.T., Maynard, A., McKenzie, H., Palmer, D., Robinson, T., Rowe, M., Thomas, A., Tweedy, J., Sheehan, R., Stockdale, A., Weaver, J., Williams, S., Wilson, C., Zhou, C., Dive, C., Cooksley, T., Palmieri, C., Freitas, A., Armstrong, A.C.
הוצא לאור ב ESMO Open (2021)

A lei geral de proteção de dados e o open finance

מאת Holz, Carlos Eduardo
יצא לאור 2022

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO...

מאת Banna, G.L., Cortellini, A., Cortinovis, D.L., Tiseo, M., Aerts, J.G.J.V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R., Rocco, D., Gori, S., De Tursi, M., Di Marino, P., Mansueto, G., Zoratto, F., Filetti, M., Montrone, M., Citarella, F., Marco, R., Cantini, L., Nigro, O., D'Argento, E., Buti, S., Minuti, G., Landi, L., Guaitoli, G., Lo Russo, G., De Toma, A., Donisi, C., Friedlaender, A., De Giglio, A., Metro, G., Porzio, G., Ficorella, C., Addeo, A.
הוצא לאור ב ESMO Open (2021)